Literature DB >> 26386480

Association Between Cannabis and Psychosis: Epidemiologic Evidence.

Suzanne H Gage1, Matthew Hickman2, Stanley Zammit2.   

Abstract

Associations between cannabis use and psychotic outcomes are consistently reported, but establishing causality from observational designs can be problematic. We review the evidence from longitudinal studies that have examined this relationship and discuss the epidemiologic evidence for and against interpreting the findings as causal. We also review the evidence identifying groups at particularly high risk of developing psychosis from using cannabis. Overall, evidence from epidemiologic studies provides strong enough evidence to warrant a public health message that cannabis use can increase the risk of psychotic disorders. However, further studies are required to determine the magnitude of this effect, to determine the effect of different strains of cannabis on risk, and to identify high-risk groups particularly susceptible to the effects of cannabis on psychosis. We also discuss complementary epidemiologic methods that can help address these questions.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cannabis; Epidemiology; Longitudinal studies; Marijuana; Psychosis; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26386480     DOI: 10.1016/j.biopsych.2015.08.001

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  82 in total

Review 1.  WHY NOT POT?: A Review of the Brain-based Risks of Cannabis.

Authors:  Kai MacDonald; Katherine Pappas
Journal:  Innov Clin Neurosci       Date:  2016-04-01

Review 2.  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Authors:  Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams
Journal:  Neurosci Biobehav Rev       Date:  2016-09-14       Impact factor: 8.989

3.  Associations between adolescent cannabis use and brain structure in psychosis.

Authors:  Hila Abush; Subroto Ghose; Erin A Van Enkevort; Brett A Clementz; Godfrey D Pearlson; John A Sweeney; Matcheri S Keshavan; Carol A Tamminga; Elena I Ivleva
Journal:  Psychiatry Res Neuroimaging       Date:  2018-03-28       Impact factor: 2.376

Review 4.  Cannabis Legalization and College Mental Health.

Authors:  Ludmila De Faria; Lillian Mezey; Aaron Winkler
Journal:  Curr Psychiatry Rep       Date:  2021-03-03       Impact factor: 5.285

5.  Psychotic Symptoms in Attention-Deficit/Hyperactivity Disorder: An Analysis of the MTA Database.

Authors:  Benedetto Vitiello; Guillermo Perez Algorta; L Eugene Arnold; Andrea L Howard; Annamarie Stehli; Brooke S G Molina
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-02-04       Impact factor: 8.829

6.  Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.

Authors:  Mary Barna Bridgeman; Daniel T Abazia
Journal:  P T       Date:  2017-03

7.  Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of U.S. Youth.

Authors:  Jason D Jones; Monica E Calkins; J Cobb Scott; Emily C Bach; Raquel E Gur
Journal:  J Adolesc Health       Date:  2017-03-17       Impact factor: 5.012

8.  Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.

Authors:  Nehal P Vadhan; Cheryl M Corcoran; Gill Bedi; John G Keilp; Margaret Haney
Journal:  Psychiatry Res       Date:  2017-08-01       Impact factor: 3.222

9.  Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory.

Authors:  Erin K Kirschmann; Michael W Pollock; Vidhya Nagarajan; Mary M Torregrossa
Journal:  Neuropsychopharmacology       Date:  2016-09-01       Impact factor: 7.853

10.  Impact of first episode psychosis treatment on heavy cannabis use: Secondary analysis on RAISE-ETP study.

Authors:  Karl C Alcover; Oladunni Oluwoye; Liat Kriegel; Sterling McPherson; Michael G McDonell
Journal:  Schizophr Res       Date:  2019-08-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.